• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国预防新冠疫情卷土重来策略之观察

Observation on China's Strategies to Prevent the Resurgence of the COVID-19 Epidemic.

作者信息

Yu Xiang, Li Na, Dong Yupeng

机构信息

School of Public Affairs, Fujian Jiangxia University, Fuzhou, Fujian Province, People's Republic of China.

School of Law, Ningbo University, Ningbo, Zhejiang Province, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2021 May 18;14:2011-2019. doi: 10.2147/RMHP.S305413. eCollection 2021.

DOI:10.2147/RMHP.S305413
PMID:34040464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8140918/
Abstract

After the first wave of the COVID-19 pandemic that began in early 2020 was brought under control, there have been some regional and small-scale cases of new infections in China. In order to prevent the resurgence of the epidemic, the Chinese government has continued the use of effective prevention and control measures in key epidemic areas. New prevention and control measures have also been developed based on the characteristics of the epidemic and the social habits of the Chinese people. The strategies applied in China include large-scale nucleic acid testing, travel health code management, and patient treatment based on a combination of Chinese and Western medicine. These measures can provide a reference point for the global public health system that is facing the pandemic. The article suggests that to prevent a pandemic, we must not only rely on vaccines and drugs, but also need to take actions and apply social measures to manage the risk of infectious diseases.

摘要

2020年初开始的新冠疫情第一波得到控制后,中国出现了一些局部和小规模的新感染病例。为防止疫情死灰复燃,中国政府在重点疫区继续采用有效的防控措施。还根据疫情特点和中国人的社会习惯制定了新的防控措施。中国采用的策略包括大规模核酸检测、行程健康码管理以及中西医结合的患者治疗。这些措施可为面临疫情的全球公共卫生系统提供参考。文章指出,要预防大流行,我们不仅要依靠疫苗和药物,还需要采取行动并应用社会措施来管理传染病风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbe/8140918/1392a412c0a8/RMHP-14-2011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbe/8140918/344d8e3a15f6/RMHP-14-2011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbe/8140918/1392a412c0a8/RMHP-14-2011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbe/8140918/344d8e3a15f6/RMHP-14-2011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbe/8140918/1392a412c0a8/RMHP-14-2011-g0002.jpg

相似文献

1
Observation on China's Strategies to Prevent the Resurgence of the COVID-19 Epidemic.中国预防新冠疫情卷土重来策略之观察
Risk Manag Healthc Policy. 2021 May 18;14:2011-2019. doi: 10.2147/RMHP.S305413. eCollection 2021.
2
Expanding public health in China: an empirical analysis of healthcare inputs and outputs.中国公共卫生的扩展:医疗投入与产出的实证分析。
Public Health. 2017 Jan;142:73-84. doi: 10.1016/j.puhe.2016.10.007. Epub 2016 Nov 22.
3
Discussion on China's anti-epidemic response based on the Protocol on Prevention and Control of Coronavirus Disease 2019 from Chinese Authority.基于中国官方《新型冠状病毒肺炎防控方案》对中国抗疫应对措施的探讨
Int J Health Plann Manage. 2022 May;37(3):1205-1220. doi: 10.1002/hpm.3419. Epub 2022 Jan 21.
4
[Reviewing and Reflecting on Nursing During the COVID-19 Pandemic].[新冠疫情期间护理工作的回顾与反思]
Hu Li Za Zhi. 2020 Dec;67(6):4-5. doi: 10.6224/JN.202012_67(6).01.
5
Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.中国新冠疫情防控公共卫生体系建设经验研究
Front Public Health. 2021 Apr 23;9:610824. doi: 10.3389/fpubh.2021.610824. eCollection 2021.
6
Environmental management strategy in response to COVID-19 in China: Based on text mining of government open information.中国应对 COVID-19 的环境管理策略:基于政府公开信息的文本挖掘。
Sci Total Environ. 2021 May 15;769:145158. doi: 10.1016/j.scitotenv.2021.145158. Epub 2021 Jan 15.
7
China's model to combat the COVID-19 epidemic: a public health emergency governance approach.中国抗击新冠肺炎疫情的模式:公共卫生应急治理之道。
Glob Health Res Policy. 2020 Jul 14;5:34. doi: 10.1186/s41256-020-00161-4. eCollection 2020.
8
Tuberculosis结核病
9
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
10
"A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.“社区系统”:防控 SARS-CoV-2 的重要基础。
Int J Health Plann Manage. 2020 Sep;35(5):1246-1249. doi: 10.1002/hpm.3005. Epub 2020 Jul 16.

引用本文的文献

1
Ethical Healthcare During Public Health Emergencies: A Focus on Non-COVID-19 Patients.公共卫生紧急事件期间的伦理医疗:聚焦非新冠患者
Risk Manag Healthc Policy. 2024 Nov 13;17:2803-2810. doi: 10.2147/RMHP.S485356. eCollection 2024.
2
Assessment of fear among the general public of Kerala, India, following a surge of COVID-19 cases.在印度喀拉拉邦新冠肺炎病例激增后,对该邦普通民众的恐惧情绪进行评估。
Med Int (Lond). 2022 Mar 15;2(2):9. doi: 10.3892/mi.2022.34. eCollection 2022 Mar-Apr.
3
Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.

本文引用的文献

1
Understanding the beginning of a pandemic: China's response to the emergence of COVID-19.了解大流行的开端:中国对 COVID-19 出现的应对。
J Infect Public Health. 2021 Mar;14(3):347-352. doi: 10.1016/j.jiph.2020.12.024. Epub 2020 Dec 29.
2
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.AXL 是 SARS-CoV-2 的候选受体,能促进肺和支气管上皮细胞的感染。
Cell Res. 2021 Feb;31(2):126-140. doi: 10.1038/s41422-020-00460-y. Epub 2021 Jan 8.
3
A Crisp(r) New Perspective on SARS-CoV-2 Biology.
在 COVID-19 疫情期间肥胖和超重的中青年 2 型糖尿病患者的远程医疗管理:一项单中心、前瞻性、随机对照研究。
PLoS One. 2022 Sep 29;17(9):e0275251. doi: 10.1371/journal.pone.0275251. eCollection 2022.
4
Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support?比利时新冠疫情期间逆转录聚合酶链反应大规模筛查中循环阈值的相关性:决策支持?
Future Virol. 2022 Sep. doi: 10.2217/fvl-2022-0020. Epub 2022 Sep 16.
5
Therapeutic Uses of Traditional Chinese Medicines Against COVID-19.中药对新型冠状病毒肺炎的治疗作用
Infect Drug Resist. 2021 Nov 27;14:5017-5026. doi: 10.2147/IDR.S328261. eCollection 2021.
6
Public Health and Private Life Under COVID-19 Vaccination Policies in China: A Legal Analysis.中国新冠疫苗接种政策下的公共卫生与私人生活:法律分析
Risk Manag Healthc Policy. 2021 Nov 12;14:4627-4638. doi: 10.2147/RMHP.S336434. eCollection 2021.
SARS-CoV-2 生物学的崭新视角
Cell. 2021 Jan 7;184(1):15-17. doi: 10.1016/j.cell.2020.12.003. Epub 2020 Dec 17.
4
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.鉴定人类细胞中感染 SARS-CoV-2 所需的宿主因子。
Cell. 2021 Jan 7;184(1):92-105.e16. doi: 10.1016/j.cell.2020.10.030. Epub 2020 Oct 24.
5
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.什么是有效的 COVID-19 疫苗?评估针对 SARS-CoV-2 的疫苗临床疗效的挑战综述。
Lancet Infect Dis. 2021 Feb;21(2):e26-e35. doi: 10.1016/S1473-3099(20)30773-8. Epub 2020 Oct 27.
6
Wearable sensor data and self-reported symptoms for COVID-19 detection.可穿戴传感器数据和自我报告症状用于 COVID-19 检测。
Nat Med. 2021 Jan;27(1):73-77. doi: 10.1038/s41591-020-1123-x. Epub 2020 Oct 29.
7
Audio Interview: A New Monoclonal Antibody for Covid-19.音频访谈:一种用于治疗新冠病毒病的新型单克隆抗体
N Engl J Med. 2020 Oct 29;383(18):e117. doi: 10.1056/NEJMe2032410.
8
Why COVID outbreaks look set to worsen this winter.为何今冬新冠疫情似乎会加剧。
Nature. 2020 Oct;586(7831):653. doi: 10.1038/d41586-020-02972-4.
9
The engines of SARS-CoV-2 spread.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的驱动因素。
Science. 2020 Oct 23;370(6515):406-407. doi: 10.1126/science.abd8755.
10
Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.免疫实践咨询委员会关于新冠病毒疫苗接种实施建议所依据的科学和伦理原则。
JAMA. 2020 Nov 24;324(20):2025-2026. doi: 10.1001/jama.2020.20847.